List of bibliographic references
Number of relevant bibliographic references: 60.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 001950 (1999) |
Douglas S. Zatechka Jr. [États-Unis] ; Nagendra R. Hegde [États-Unis] ; Kandasamy Hariharan [États-Unis] ; S. Srikumaran [États-Unis] | Identification of murine cytotoxic T-lymphocyte epitopes of bovine herpesvirus 1 |
| 001973 (1998) |
F. M. Fernandez [États-Unis, Argentine] ; M. E. Conner [États-Unis] ; D. C. Hodgins [États-Unis] ; A. V. Parwani [États-Unis] ; P. R. Nielsen [États-Unis] ; S. E. Crawford [Argentine] ; M. K. Estes [Argentine] ; L. J. Saif [États-Unis] | Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines |
| 001998 (1997) |
Terecita D. Yule [États-Unis] ; Mark B. Roth [États-Unis] ; Kimberly Dreier [États-Unis] ; Anthony F. Johnson [États-Unis] ; Melissa Palmer-Densmore [États-Unis] ; Kris Simmons [États-Unis] ; Robert Fanton [États-Unis] | Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease |
| 001A43 (1995) |
| Preparation of a helicase region coded by hepatitis C virus; hepatitis C virus recombinant helicase production via gene cloning and expression in Spodoptera frugiperda insect cell culture using baculovirus vector |
| 001A44 (1995) |
| Pathogen strain Borrelia burgdorferi ZS7 (DSM 5527); for the production of passive antibodies for the treatment of Lyme disease |
| 001A45 (1995) |
| New epitope-bearing portions of Entamoeba histolytica ; recombinant non-glycosylated epitope production and expression in prokaryote host cell, for application in a recombinant vaccine |
| 001A47 (1995) |
| Mengo virus as a vector for expression of foreign polypeptides; hepatitis A virus, HIV virus, rabies virus, foot-and-mouth-disease virus, coronat virus, Rous sarcoma virus, herpes virus, etc., live attenuated recombinant vaccine |
| 001A99 (1993) |
| Vaccine containing cattle papilloma virus-2 and/or cattle papilloma virus-4 L2 protein; for use as recombinant vaccine or in tumour therapy |
| 001B03 (1993) |
| Retrovirus-mediated recombinant fusion protein preparation; vector with Rous-sarcoma virus gag gene myristylation site for recombinant vaccine production in CV-1, COS-1, NIH3T3 or turkey embryo fibroblast cell culture as membranous particle |
| 001B05 (1993) |
| Peptides corresponding to regions of HPV-16 E1 and E2 proteins: human recombinant papilloma virus-16 E1 and E2 protein sero-reactive region and monoclonal antibody useful in cervix carcinoma vaccine, diagnosis |
| 001B08 (1993) |
| New nucleic acid encoding E2 protein of canine corona virus; dog corona virus recombinant E2 protein production; may be used in recombinant vaccine production |
| 001B09 (1993) |
| Induction of immunological response to mammal pathogen; rabies virus, cattle leukaemia virus, cat leukaemia virus or herpes simplex virus antigen gene cloning in an avipox virus vector for use as a recombinant vaccine |
| 001B49 (1992) |
| Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses |
| 001B50 (1992) |
| Vaccine comprising anti-idiotype antibody conjugate; induces production of neutralizing antibody (human monoclonal antibody, chimeric antibody or FAb, F(Ab′) 2 or Fv fragment) against HIV virus-1 |
| 001B55 (1992) |
| Recombinant pox virus containing Morbilli virus DNA; expression of e.g. measles virus haemagglutinin glycoprotein in host for construction of a potential recombinant vaccine against dog distemper virus |
| 001B56 (1992) |
| Recombinant feline corona virus-S protein; expressed as galactokinase fusion protein and useful as reconbinant vaccine, therapeutic and diagnostic agents for feline-infectious-peritonitis virus |
| 001B59 (1992) |
| Nucleic acid constructs, malaria polypeptides and vaccines; recombinant malaria serine-repeat antigen production in yeast for the construction of a recombinant vaccine |
| 001B60 (1992) |
| New gene fragment encoding rabies virus glycoprotein; DNA sequence expression in eukaryote cell culture and application to recombinant vaccine construction |
| 001B63 (1992) |
| Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast |
| 001B71 (1992) |
| Antigen composition comprising PEB1 and/or PEB3 antigen from Campylobacter jejuni ; useful as vaccine and for diagnosis of C. jejuni and Campylobacter coli infections |
| 001C54 (1989) |
| Synthetic peptide antigen corresponding to the major sites of T-lymphocyte recognition within the HIV virus envelope protein: recombinant vaccine production |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/ISSN.i -k "JVAC"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/ISSN.i \
-Sk "JVAC" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Main
|étape= Merge
|type= indexItem
|index= ISSN.i
|clé= JVAC
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021 |  |
